Biologically Clearing the Barriers to Wound Healing: Changing the Wound Healing Environment through Debridement

Faculty

Jeffrey Lehrman, DPM, FASPS, MAPWCA, CPC
Lehrman Consulting, LLC
Fort Collins, Colorado 

Chandan K. Sen, PhD
Vice Chair of Research
School of Medicine and Department of Surgery
Indiana University
Indianapolis, Indiana

Ira Herman, PhD
Professor
Developmental, Molecular, and Chemical Biology
Tufts University
Boston, Massachusetts

Dot Weir, RN, CWON, CWS
Catholic Health Advanced Wound Healing
Cheektowaga, NY

PROVIDER STATEMENT

Provided by HMP Education, an HMP Global Company.

For questions regarding this educational activity, please call 609-371-1137 or email accreditation@hmpglobal.com.

INTENDED LEARNERS

This activity is designed for physicians, podiatrists, physical therapists, pharmacists, and nurses involved in the treatment of patients with chronic wounds.

LEARNING OBJECTIVES

After completing this activity, participants should be able to:

• Assess recent data on the effects of bioactive peptides in the wound healing environment and the role of collagenase as a debrider
• Explore recent data on the role of enzymatic debridement in controlling inflammation and biofilm infection in the chronic wound
• Translate scientific data on enzymatic debridement to clinical   relevance across the continuum of care

CLAIMING CREDIT

To be eligible for documentation of credit, participants must complete the educational activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. Upon completing the activity, there will be instructions on how to complete the evaluation and print a certificate or other documentation of credit.

Participants who have successfully completed the live version of this activity are not eligible for credit for this enduring material.

Release Date: May 18, 2016
Expiration date: December 30, 2023
Date of last review: January 31, 2020
Estimated time to complete: 1 hour

There is no fee associated with this activity.

CONTINUING EDUCATION

In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Note: This statement is not an indication of approved credits. Please see below for full accreditation details, including credit types and totals, for this activity. 

PHYSICIANS

HMP Education designates this internet enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSING

This continuing nursing education internet enduring activity awards 1.00 contact hour.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.00 contact hour. 

NURSE PRACTITIONER

American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit^TM from organizations accredited by the ACCME.

PHARMACY

This knowledge-based activity is approved for 1 contact hour (.1 CEU) of continuing pharmacy education (UAN JA0006201-0000-22-241-H01-P)

PHYSICIAN ASSISTANTS

HMP Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This internet enduring activity is designated for 1.00 AAPA Category 1 credit. PAs should only claim credit commensurate with the extent of their participation.

PODIATRY

HMP Education is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. HMP Education has approved this internet enduring activity for a maximum of 1.00 continuing education contact hour.

USE OF PROPRIETARY NAMES

This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.

UNAPPROVED AND/OR INVESTIGATIONAL USES OF DRUGS AND DEVICES

This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of NACCME.

The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.

Neither HMP Education nor any of its subsidiaries or affiliates is affiliated with, or formally endorsed by a medical society.

The opinions expressed in this educational activity are those of the faculty and are not attributable to HMP Education or HMP. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

HMP Education is an independent provider of continuing medical education. HMP Education has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.

In accordance with our disclosure policies, HMP Education is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to, and mitigating, all perceived or real conflicts of interest between any individual with control over the content and any ineligible company (commercial interest) as defined by the ACCME.

Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose:

1. Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company, and;
2. Any investigational, off-label, or non-FDA approved content or discussion

HMP Education has reviewed these disclosures, assigned relevance based on the relationship and scope of content, and identified those with the potential to compromise the goals and educational integrity of the education. Relevant relationships, or lack thereof, are shared with the learner.

Education has been independently peer-reviewed to validate content, mitigate identified conflicts of interest, and ensure:

1. All recommendations involving clinical medicine is based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients.
2. All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis.
3. Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional.

FACULTY

The faculty has reported the following:

Dr. Herman: Senior Director - Biological Sciences, Precision Healing, Inc.

Dr. Lehrman: Speakers Bureau - Organogenesis, Smith & Nephew

Dr. Sen: Consultant – Vomaris Innovations, Inc., SouthWest Technologies, Inc 

Ms. Weir: Consultant—Misonix, Moleculight, Urgo; Speaker's Bereau—3M/KCI, Lohmann & Rauscher, Medline, Molnlycke, Organogenesis, Smith & Nephew

CLINICAL REVIEWER

Daniel Federman, MD, FACP
Professor of Medicine
Yale University School of Medicine
Associate Chief of Medicine
VA Connecticut Healthcare System
West Haven, Connecticut

Dr. Federman has disclosed no relevant financial relationships with any commercial interests.

PLANNING COMMITTEE

Susie Seaman, NP, MSN, CWOCN (nurse planner)
Wound Clinic, Family Health Centers of San Diego
San Diego, California

Ms. Seaman has disclosed no relevant financial relationship with any ineligible company (commercial interest).

HMP Education planners and staff include Kristin Ciszeski, Samantha Joy, Tiffney Oliver, Randy Robbin, and Andrea Zimmerman.

No HMP Education planner or staff has disclosed a relevant financial relationship with any ineligible company (commercial interest).

ADA STATEMENT

HMP Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.

PRIVACY POLICY

HMP Education protects the privacy of personal and other information regarding participants, educational partners, and joint providers. HMP Education and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. HMP Education maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2022 by HMP Education. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Education.

GRIEVANCE POLICY

Any participant wanting to file a grievance with respect to any aspect of a continuing education activity accredited by HMP Education may contact Samantha Joy, Senior Manager, Accreditation and Compliance, by phone at 609-371-1137, by email at accreditation@hmpglobal.com or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. Ms. Joy will review the grievance and respond within 30 days of receiving the complaint.

COMMERCIAL SUPPORT

Supported by an educational grant from Smith & Nephew.